DALLAS, April 20, 2015 /PRNewswire/ --
According to a new market research report "Blood Culture Test Market by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, Reference Laboratory, Clinical Laboratory, Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, the Blood Culture Test Market is expected to reach around $3.473 Billion by 2019 with a CAGR of around 6.8% during the forecast period (2014 to 2019).
Browse 178 market data tables and 37 figures spread through 250 pages and in-depth TOC on "Blood Culture Test Market"
Early buyers will receive 10% customization on this report.
The Blood Culture Test Market is segmented on the basis of methods, products, applications, end users, and regions. On the basis of products, the market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the Blood Culture Test Market in 2014. The large share of this segment is attributed to the rising demand for rapid diagnostic techniques which provide quick results over a short duration of time.
On the basis of regions, the Blood Culture Test Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2014, North America accounted for the largest share of this market owing to the increasing blood stream infections (BSI), growing aging population, high rate of infectious diseases, and technological advancements.
The key market players in the Blood Culture Market include bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Bruker Corporation (U.S.), Cepheid (U.S.), Alere, Inc. (U.S.), Abbott Laboratories (U.S.), and Nanosphere, Inc. (U.S.).
Browse Related Reports:
Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019
Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252